International Clinical Trial: Research on an Intelligent System for Interpreting Anti-Nuclear Antibody Patterns and Titers Based on Artificial Intelligence Algorithms

Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (ChiCTR2600128477) titled 'Research on an Intelligent System for Interpreting Anti-Nuclear Antibody Patterns and Titers Based on Artificial Intelligence Algorithms' on July 21.

Study Type: Observational study

Study Design: Sequential

Primary Sponsor: Renji Hospital, Shanghai Jiao Tong University School of Medicine

Condition: Autoimmune disease

Intervention: ANA pattern negative:None ANA single pattern positive:None ANA compound pattern positive:None

Recruitment Status: Recruiting

Phase: N/A

Date of First Enrollment: 2026-01-01

Target Sample Size: ANA pattern negative:1000;ANA single pattern positive:5800;ANA compound pattern...